ADRXADARx Pharmaceuticals, Inc.
- Market cap
- $1.88B
- as of 2026-10-23
- Latest close
- $17.63
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
5 insiders bought $87.75M between Sep 28.
Under the default rule (14d · ≥2 insiders · all roles).
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | Holding change | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Sr One Capital Management, LLC | Sep 28 | Sep 29 | P | 592,593 | $17.00 | Purchase +$10,074,081 | 5,554,094 | +11.9% | No | Form 4 |
| Sr One Capital Management, LLC | Sep 28 | Sep 29 | P | 414,814 | $17.00 | Purchase +$7,051,838 | 1,953,505 | +27.0% | No | Form 4 |
| Sr One Capital Management, LLC | Sep 28 | Sep 29 | P | 592,593 | $17.00 | Purchase +$10,074,081 | 592,593 | not reported | No | Form 4 |
| George Simeon | Sep 28 | Sep 29 | P | 592,593 | $17.00 | Purchase +$10,074,081 | 5,554,094 | +11.9% | No | Form 4 |
| George Simeon | Sep 28 | Sep 29 | P | 414,814 | $17.00 | Purchase +$7,051,838 | 1,953,505 | +27.0% | No | Form 4 |
| George Simeon | Sep 28 | Sep 29 | P | 592,593 | $17.00 | Purchase +$10,074,081 | 592,593 | not reported | No | Form 4 |
| Chimovits Erez | Sep 28 | Sep 30 | P | 61,516 | $17.00 | Purchase +$1,045,772 | 9,292,025 | +0.7% | No | Form 4 |
| Gordon Carl L | Sep 28 | Sep 30 | P | 300,249 | $17.00 | Purchase +$5,104,233 | 14,325,529 | +2.1% | No | Form 4 |
| Gordon Carl L | Sep 28 | Sep 30 | P | 61,516 | $17.00 | Purchase +$1,045,772 | 9,292,025 | +0.7% | No | Form 4 |
| Gordon Carl L | Sep 28 | Sep 30 | P | 588,235 | $17.00 | Purchase +$9,999,995 | 588,235 | not reported | No | Form 4 |
| Orbimed Advisors LLC | Sep 28 | Sep 30 | P | 300,249 | $17.00 | Purchase +$5,104,233 | 14,325,529 | +2.1% | No | Form 4 |
| Orbimed Advisors LLC | Sep 28 | Sep 30 | P | 61,516 | $17.00 | Purchase +$1,045,772 | 9,292,025 | +0.7% | No | Form 4 |
| Orbimed Advisors LLC | Sep 28 | Sep 30 | P | 588,235 | $17.00 | Purchase +$9,999,995 | 588,235 | not reported | No | Form 4 |
Form 4 historysince 2026-09-28
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| OrbiMed Genesis GP LLC | Sep 28 | Sep 30 | C | 10,690,530 | not reported | not reported | 10,690,530 | No | Form 4 |
| OrbiMed Genesis GP LLC | Sep 28 | Sep 30 | C | 2,000,962 | not reported | not reported | 12,691,492 | No | Form 4 |
| OrbiMed Genesis GP LLC | Sep 28 | Sep 30 | C | 769,601 | not reported | not reported | 13,461,093 | No | Form 4 |
| OrbiMed Genesis GP LLC | Sep 28 | Sep 30 | C | 564,187 | not reported | not reported | 14,025,280 | No | Form 4 |
| OrbiMed Genesis GP LLC | Sep 28 | Sep 30 | P | 300,249 | $17.00 | Purchase +$5,104,233 | 14,325,529 | No | Form 4 |
| OrbiMed Genesis GP LLC | Sep 28 | Sep 30 | C | 7,127,019 | not reported | not reported | 7,127,019 | No | Form 4 |
| OrbiMed Genesis GP LLC | Sep 28 | Sep 30 | C | 1,333,975 | not reported | not reported | 8,460,994 | No | Form 4 |
| OrbiMed Genesis GP LLC | Sep 28 | Sep 30 | C | 513,067 | not reported | not reported | 8,974,061 | No | Form 4 |
| OrbiMed Genesis GP LLC | Sep 28 | Sep 30 | C | 256,448 | not reported | not reported | 9,230,509 | No | Form 4 |
| OrbiMed Genesis GP LLC | Sep 28 | Sep 30 | P | 61,516 | $17.00 | Purchase +$1,045,772 | 9,292,025 | No | Form 4 |
| OrbiMed Genesis GP LLC | Sep 28 | Sep 30 | P | 588,235 | $17.00 | Purchase +$9,999,995 | 588,235 | No | Form 4 |
| OrbiMed Genesis GP LLC | Sep 28 | Sep 30 | C · derivative | 10,690,530 | $0.00 | $0 | not reported | No | Form 4 |
| OrbiMed Genesis GP LLC | Sep 28 | Sep 30 | C · derivative | 2,000,962 | $0.00 | $0 | not reported | No | Form 4 |
| OrbiMed Genesis GP LLC | Sep 28 | Sep 30 | C · derivative | 769,601 | $0.00 | $0 | not reported | No | Form 4 |
| OrbiMed Genesis GP LLC | Sep 28 | Sep 30 | C · derivative | 564,187 | $0.00 | $0 | not reported | No | Form 4 |
| OrbiMed Genesis GP LLC | Sep 28 | Sep 30 | C · derivative | 7,127,019 | $0.00 | $0 | not reported | No | Form 4 |
| OrbiMed Genesis GP LLC | Sep 28 | Sep 30 | C · derivative | 1,333,975 | $0.00 | $0 | not reported | No | Form 4 |
| OrbiMed Genesis GP LLC | Sep 28 | Sep 30 | C · derivative | 513,067 | $0.00 | $0 | not reported | No | Form 4 |
| OrbiMed Genesis GP LLC | Sep 28 | Sep 30 | C · derivative | 256,448 | $0.00 | $0 | not reported | No | Form 4 |
| Gordon Carl L | Sep 28 | Sep 30 | C | 10,690,530 | not reported | not reported | 10,690,530 | No | Form 4 |
| Gordon Carl L | Sep 28 | Sep 30 | C | 2,000,962 | not reported | not reported | 12,691,492 | No | Form 4 |
| Gordon Carl L | Sep 28 | Sep 30 | C | 769,601 | not reported | not reported | 13,461,093 | No | Form 4 |
| Gordon Carl L | Sep 28 | Sep 30 | C | 564,187 | not reported | not reported | 14,025,280 | No | Form 4 |
| Gordon Carl L | Sep 28 | Sep 30 | P | 300,249 | $17.00 | Purchase +$5,104,233 | 14,325,529 | No | Form 4 |
| Gordon Carl L | Sep 28 | Sep 30 | C | 7,127,019 | not reported | not reported | 7,127,019 | No | Form 4 |
| Gordon Carl L | Sep 28 | Sep 30 | C | 1,333,975 | not reported | not reported | 8,460,994 | No | Form 4 |
| Gordon Carl L | Sep 28 | Sep 30 | C | 513,067 | not reported | not reported | 8,974,061 | No | Form 4 |
| Gordon Carl L | Sep 28 | Sep 30 | C | 256,448 | not reported | not reported | 9,230,509 | No | Form 4 |
| Gordon Carl L | Sep 28 | Sep 30 | P | 61,516 | $17.00 | Purchase +$1,045,772 | 9,292,025 | No | Form 4 |
| Gordon Carl L | Sep 28 | Sep 30 | P | 588,235 | $17.00 | Purchase +$9,999,995 | 588,235 | No | Form 4 |
| Gordon Carl L | Sep 28 | Sep 30 | C · derivative | 10,690,530 | $0.00 | $0 | not reported | No | Form 4 |
| Gordon Carl L | Sep 28 | Sep 30 | C · derivative | 2,000,962 | $0.00 | $0 | not reported | No | Form 4 |
| Gordon Carl L | Sep 28 | Sep 30 | C · derivative | 769,601 | $0.00 | $0 | not reported | No | Form 4 |
| Gordon Carl L | Sep 28 | Sep 30 | C · derivative | 564,187 | $0.00 | $0 | not reported | No | Form 4 |
| Gordon Carl L | Sep 28 | Sep 30 | C · derivative | 7,127,019 | $0.00 | $0 | not reported | No | Form 4 |
| Gordon Carl L | Sep 28 | Sep 30 | C · derivative | 1,333,975 | $0.00 | $0 | not reported | No | Form 4 |
| Gordon Carl L | Sep 28 | Sep 30 | C · derivative | 513,067 | $0.00 | $0 | not reported | No | Form 4 |
| Gordon Carl L | Sep 28 | Sep 30 | C · derivative | 256,448 | $0.00 | $0 | not reported | No | Form 4 |
| Chimovits Erez | Sep 28 | Sep 30 | C | 7,127,019 | not reported | not reported | 7,127,019 | No | Form 4 |
| Chimovits Erez | Sep 28 | Sep 30 | C | 1,333,975 | not reported | not reported | 8,460,994 | No | Form 4 |
| Chimovits Erez | Sep 28 | Sep 30 | C | 513,067 | not reported | not reported | 8,974,061 | No | Form 4 |
| Chimovits Erez | Sep 28 | Sep 30 | C | 256,448 | not reported | not reported | 9,230,509 | No | Form 4 |
| Chimovits Erez | Sep 28 | Sep 30 | P | 61,516 | $17.00 | Purchase +$1,045,772 | 9,292,025 | No | Form 4 |
| Chimovits Erez | Sep 28 | Sep 30 | C · derivative | 7,127,019 | $0.00 | $0 | not reported | No | Form 4 |
| Chimovits Erez | Sep 28 | Sep 30 | C · derivative | 1,333,975 | $0.00 | $0 | not reported | No | Form 4 |
| Chimovits Erez | Sep 28 | Sep 30 | C · derivative | 513,067 | $0.00 | $0 | not reported | No | Form 4 |
| Chimovits Erez | Sep 28 | Sep 30 | C · derivative | 256,448 | $0.00 | $0 | not reported | No | Form 4 |
| George Simeon | Sep 28 | Sep 29 | C | 3,334,938 | not reported | not reported | 3,334,938 | No | Form 4 |
| George Simeon | Sep 28 | Sep 29 | C | 1,113,666 | not reported | not reported | 4,448,604 | No | Form 4 |
| George Simeon | Sep 28 | Sep 29 | C | 512,897 | not reported | not reported | 4,961,501 | No | Form 4 |
| George Simeon | Sep 28 | Sep 29 | P | 592,593 | $17.00 | Purchase +$10,074,081 | 5,554,094 | No | Form 4 |
| George Simeon | Sep 28 | Sep 29 | C | 1,538,691 | not reported | not reported | 1,538,691 | No | Form 4 |
| George Simeon | Sep 28 | Sep 29 | P | 414,814 | $17.00 | Purchase +$7,051,838 | 1,953,505 | No | Form 4 |
| George Simeon | Sep 28 | Sep 29 | C | 1,667,468 | not reported | not reported | 1,667,468 | No | Form 4 |
| George Simeon | Sep 28 | Sep 29 | C | 169,001 | not reported | not reported | 1,836,469 | No | Form 4 |
| George Simeon | Sep 28 | Sep 29 | P | 592,593 | $17.00 | Purchase +$10,074,081 | 592,593 | No | Form 4 |
| George Simeon | Sep 28 | Sep 29 | C · derivative | 3,907,547 | $0.00 | $0 | not reported | No | Form 4 |
| George Simeon | Sep 28 | Sep 29 | C · derivative | 1,304,883 | $0.00 | $0 | not reported | No | Form 4 |
| George Simeon | Sep 28 | Sep 29 | C · derivative | 600,962 | $0.00 | $0 | not reported | No | Form 4 |
| George Simeon | Sep 28 | Sep 29 | C · derivative | 1,802,885 | $0.00 | $0 | not reported | No | Form 4 |
| George Simeon | Sep 28 | Sep 29 | C · derivative | 1,953,773 | $0.00 | $0 | not reported | No | Form 4 |
| George Simeon | Sep 28 | Sep 29 | C · derivative | 198,019 | $0.00 | $0 | not reported | No | Form 4 |
| Sr One Capital Management, LLC | Sep 28 | Sep 29 | C | 3,334,938 | not reported | not reported | 3,334,938 | No | Form 4 |
| Sr One Capital Management, LLC | Sep 28 | Sep 29 | C | 1,113,666 | not reported | not reported | 4,448,604 | No | Form 4 |
| Sr One Capital Management, LLC | Sep 28 | Sep 29 | C | 512,897 | not reported | not reported | 4,961,501 | No | Form 4 |
| Sr One Capital Management, LLC | Sep 28 | Sep 29 | P | 592,593 | $17.00 | Purchase +$10,074,081 | 5,554,094 | No | Form 4 |
| Sr One Capital Management, LLC | Sep 28 | Sep 29 | C | 1,538,691 | not reported | not reported | 1,538,691 | No | Form 4 |
| Sr One Capital Management, LLC | Sep 28 | Sep 29 | P | 414,814 | $17.00 | Purchase +$7,051,838 | 1,953,505 | No | Form 4 |
| Sr One Capital Management, LLC | Sep 28 | Sep 29 | C | 1,667,468 | not reported | not reported | 1,667,468 | No | Form 4 |
| Sr One Capital Management, LLC | Sep 28 | Sep 29 | C | 169,001 | not reported | not reported | 1,836,469 | No | Form 4 |
| Sr One Capital Management, LLC | Sep 28 | Sep 29 | P | 592,593 | $17.00 | Purchase +$10,074,081 | 592,593 | No | Form 4 |
| Sr One Capital Management, LLC | Sep 28 | Sep 29 | C · derivative | 3,907,547 | $0.00 | $0 | not reported | No | Form 4 |
| Sr One Capital Management, LLC | Sep 28 | Sep 29 | C · derivative | 1,304,883 | $0.00 | $0 | not reported | No | Form 4 |
| Sr One Capital Management, LLC | Sep 28 | Sep 29 | C · derivative | 600,962 | $0.00 | $0 | not reported | No | Form 4 |
| Sr One Capital Management, LLC | Sep 28 | Sep 29 | C · derivative | 1,802,885 | $0.00 | $0 | not reported | No | Form 4 |
| Sr One Capital Management, LLC | Sep 28 | Sep 29 | C · derivative | 1,953,773 | $0.00 | $0 | not reported | No | Form 4 |
| Sr One Capital Management, LLC | Sep 28 | Sep 29 | C · derivative | 198,019 | $0.00 | $0 | not reported | No | Form 4 |
| LAV Fund VI, L.P. | Sep 28 | Sep 29 | C | 8,908,775 | not reported | not reported | 8,908,775 | No | Form 4 |
| LAV Fund VI, L.P. | Sep 28 | Sep 29 | C | 1,667,469 | not reported | not reported | 10,576,244 | No | Form 4 |
| LAV Fund VI, L.P. | Sep 28 | Sep 29 | C | 513,067 | not reported | not reported | 11,089,311 | No | Form 4 |
| LAV Fund VI, L.P. | Sep 28 | Sep 29 | C | 153,868 | not reported | not reported | 11,243,179 | No | Form 4 |
| LAV Fund VI, L.P. | Sep 28 | Sep 29 | C | 307,738 | not reported | not reported | 307,738 | No | Form 4 |
| LAV Fund VI, L.P. | Sep 28 | Sep 29 | C | 307,738 | not reported | not reported | 307,738 | No | Form 4 |
| LAV Fund VI, L.P. | Sep 28 | Sep 29 | C · derivative | 10,438,412 | $0.00 | $0 | not reported | No | Form 4 |
| LAV Fund VI, L.P. | Sep 28 | Sep 29 | C · derivative | 1,953,774 | $0.00 | $0 | not reported | No | Form 4 |
| LAV Fund VI, L.P. | Sep 28 | Sep 29 | C · derivative | 601,161 | $0.00 | $0 | not reported | No | Form 4 |
| LAV Fund VI, L.P. | Sep 28 | Sep 29 | C · derivative | 180,288 | $0.00 | $0 | not reported | No | Form 4 |
| LAV Fund VI, L.P. | Sep 28 | Sep 29 | C · derivative | 360,577 | $0.00 | $0 | not reported | No | Form 4 |
| LAV Fund VI, L.P. | Sep 28 | Sep 29 | C · derivative | 360,577 | $0.00 | $0 | not reported | No | Form 4 |
| Li ZhenPresident and CEO | Sep 24 | Sep 28 | A · derivative | 1,024,152 | $17.00 | $17,410,584 | 1,024,152 | No | Form 4 |
| Fisk RyanCFO and CBO | Sep 24 | Sep 28 | A · derivative | 170,692 | $17.00 | $2,901,764 | 170,692 | No | Form 4 |
| Ackles Robert WilliamChief People Officer | Sep 24 | Sep 28 | A · derivative | 85,346 | $17.00 | $1,450,882 | 85,346 | No | Form 4 |
| Zhu Rui (NMN)Chief Technology Officer | Sep 24 | Sep 28 | A · derivative | 512,076 | $17.00 | $8,705,292 | 512,076 | No | Form 4 |
| MacLeod Alan RobertChief Scientific Officer | Sep 24 | Sep 28 | A · derivative | 170,692 | $17.00 | $2,901,764 | 170,692 | No | Form 4 |